SD Biotechnologies Past Earnings Performance

Past criteria checks 0/6

SD Biotechnologies's earnings have been declining at an average annual rate of -57%, while the Personal Products industry saw earnings declining at 1.3% annually. Revenues have been declining at an average rate of 9.5% per year.

Key information

-57.0%

Earnings growth rate

-54.7%

EPS growth rate

Personal Products Industry Growth	3.8%
Revenue growth rate	-9.5%
Return on equity	-289.2%
Net Margin	-60.6%
Last Earnings Update	31 Mar 2023

Recent past performance updates

No updates

Recent updates

How Much Of SD Biotechnologies Co., Ltd. (KOSDAQ:217480) Do Insiders Own?

Feb 21

SD Biotechnologies' (KOSDAQ:217480) Stock Price Has Reduced 58% In The Past Three Years

Nov 25

Revenue & Expenses Breakdown

How SD Biotechnologies makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A217480 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Mar 23	87,988	-53,323	54,152	2,590
31 Dec 22	93,676	-50,376	56,239	3,116
30 Sep 22	101,505	-24,062	55,413	3,822
30 Jun 22	107,379	-23,777	59,195	4,234
31 Mar 22	112,569	-41,685	60,935	4,895
31 Dec 21	124,681	-43,567	63,401	5,314
30 Sep 21	133,963	-37,902	66,899	5,314
30 Jun 21	137,083	-34,971	63,313	4,832
31 Mar 21	142,620	-18,682	55,976	4,194
31 Dec 20	140,725	-8,668	52,025	3,350
30 Sep 20	147,570	-20,904	51,940	3,050
30 Jun 20	152,329	-17,212	54,121	3,213
31 Mar 20	155,993	-16,843	59,703	3,248
31 Dec 19	156,259	-18,445	62,447	3,414
30 Sep 19	150,764	-3,380	60,731	3,872
30 Jun 19	151,158	-1,614	59,848	3,541
31 Mar 19	151,632	3,166	58,242	3,480
31 Dec 18	156,624	6,577	60,396	3,311
30 Sep 18	163,754	13,671	59,890	3,430
30 Jun 18	156,377	17,273	53,536	3,475
31 Mar 18	143,388	14,019	53,552	3,231
31 Dec 17	127,402	14,141	45,311	3,138
30 Sep 17	106,638	15,496	38,441	2,311
30 Jun 17	106,413	17,664	39,465	1,874
31 Mar 17	103,581	20,723	34,112	1,702
31 Dec 16	104,692	22,460	35,369	1,470
30 Sep 16	97,197	17,949	34,166	1,305
31 Dec 15	74,634	18,287	16,660	733
31 Dec 14	9,695	2,588	774	55

Quality Earnings: A217480 is currently unprofitable.

Growing Profit Margin: A217480 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A217480 is unprofitable, and losses have increased over the past 5 years at a rate of 57% per year.

Accelerating Growth: Unable to compare A217480's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A217480 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (11.9%).

Return on Equity

High ROE: A217480 has a negative Return on Equity (-289.24%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/06/19 07:20
End of Day Share Price	2023/03/22 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SD Biotechnologies Co., Ltd. is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hyeon Jin Park	DB Financial Investment Co. Ltd.
Jongsun Park	Eugene Investment & Securities Co Ltd.
Yoon Seo Kim	Shinhan Investment Corp.